Recall Register

Drug recall: Topicort (desoximetasone) Cream USP, 0.05%, Packaged in 5 g Tubes, Professional Sample Only, Rx Only. Mfd. by: Taro…

Class III FDA enforcement event 73829. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Subpotent Drug

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Taro Pharmaceuticals U.S.A., Inc. started this drug recall on 31 Mar 2016. The firm address in the FDA record is in Hawthorne, NY. FDA put the recall in Class III. FDA event 73829 has 1 product record. The first FDA enforcement report date is 8 Jun 2016. The record gives the status Terminated, with the termination date 6 Jun 2018.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

U.S. Including: CA, CT, MA, MD, NY, NJ, OK, TX, and WA

Recalling firm

Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 73829: product records
Recall numberProductQuantityClassStatusReport date
D-0950-2016Topicort (desoximetasone) Cream USP, 0.05%, Packaged in 5 g Tubes, Professional Sample Only, Rx Only. Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: TaroPharma a division of Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC: 51672-5205-5.62,800 TubesClass IIITerminated8 Jun 2016

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2016
288
Share of these events in Class III
43%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
21

Other events of the firm

Other FDA enforcement events of Taro Pharmaceuticals U.S.A., Inc.
InitiatedProduct (first record)TypeClassRecords
7 Aug 2024Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, ODrugClass III1
25 Feb 2022Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro PharmaceuticaDrugClass III1
15 Dec 2021Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, DrugClass I1
8 Jan 2021Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2DrugClass II1
17 Nov 2020CVS Health Athlete's Foot Cream, Clotrimazole Cream USP, 1%, Antifungal, NET WT 1 OZ (28.4 g) Distributed by: CVS PharmaDrugClass II10
20 Jul 2020Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For EDrugClass III1
7 Feb 2020Phenytoin Oral Suspension USP, 125 mg/5 mL potency, 8 fl oz (237 mL) Rx Only Mfd. by: Taro Pharmaceuticals Industries LtDrugClass I1
20 Dec 2019Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, IsrDrugClass I1
27 Sep 2019Ibuprofen Oral Suspension USP, 100 mg/5 mL, 4 fl. oz., (118 mL), Rx only, Manufactured by: Taro Pharmaceuticals, Inc., BDrugClass II5
19 Oct 2018Children's 24 Hour Allergy (cetirizine hydrochloride) Oral Solution 1 mg/mL, Bubble Gum Flavor, Sugar Free/Dye Free, 4 FDrugClass II3

Taro Pharmaceuticals U.S.A., Inc.: all 21 events

Official channels

Cite this page

Recall Register. FDA enforcement event 73829. https://recallregister.com/fda/iii/73829/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: U.S. Including: CA, CT, MA, MD, NY, NJ, OK, TX, and WA
What quantity of product is in FDA event 73829?
The FDA record gives this quantity: 62,800 Tubes
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2016 have the same class?
43% of the 288 drug events that started in 2016 are in Class III.